CHIBIOFARAM Department, University of Messina, Messina, Italy.
NEUROFARBA Department, University of Florence, Florence, Italy.
Arch Pharm (Weinheim). 2022 Oct;355(10):e2200070. doi: 10.1002/ardp.202200070. Epub 2022 Jun 23.
This study reports our continued efforts to identify inhibitors capable of targeting carbonic anhydrases (CAs) expressed in bacteria. Based on previously identified chemotypes, we designed and synthesized new analogs that were screened toward the α, β, and γ classes encoded in Vibrio cholerae (Vch). The K values measured in the stopped-flow hydrase assay revealed that very simple structural modifications might induce a relevant impact on the inhibitory effects as well as the selectivity profile over ubiquitous human isozymes (hCA I/II). Unfortunately, the best active VchCA inhibitors demonstrated a dramatic loss of hCA II selectivity when compared to previously reported compounds. Among the new series of sulfonamides, several molecules proved to be about sevenfold more potent against VchCAγ than the reference compound acetazolamide, thus furnishing new insights for further development of inhibitors targeting CAs expressed in bacteria.
本研究报告了我们在鉴定能够靶向细菌中表达的碳酸酐酶(CA)的抑制剂方面的持续努力。基于先前确定的化学型,我们设计并合成了新的类似物,并针对霍乱弧菌(Vch)中编码的α、β和γ类进行了筛选。在停流水解酶测定中测量的 K 值表明,非常简单的结构修饰可能会对抑制作用以及对普遍存在的人同工酶(hCA I/II)的选择性特征产生相关影响。不幸的是,与先前报道的化合物相比,最好的活性 VchCA 抑制剂对 hCA II 的选择性显著降低。在所研究的一系列磺胺类化合物中,有几个分子对 VchCAγ 的活性比参考化合物乙酰唑胺高约 7 倍,这为进一步开发针对细菌中表达的 CA 的抑制剂提供了新的思路。